No notable correlations were found between sPD-L1 and sPD-1 levels and immune cell populations like CD3+, CD4+, CD8+, and NK cells, which typically exhibits antitumor effects in whole PCa patients population. The gene discussed is CD8A; the disease is posterior cortical atrophy.